SCHEMBL978050

SCHEMBL978050

CO[Si](CCCNc1nc(N)nc(N(CCC[Si](OC)(OC)OC)CCC[Si](OC)(OC)OC)n1)(OC)OC

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.34
HTR1A P08908 3/20 0.34
DRD2 P14416 3/20 0.34
HTR2A P28223 3/20 0.34
HTR6 P50406 3/20 0.34
MBNL1 Q9NR56 1/20 0.33
SLC29A1 Q99808 2/20 0.33
MEN1 O00255 2/20 0.32
LMNA P02545 2/20 0.32
KMT2A Q03164 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP3 P42574 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978140 0.95 SLC29A1 (0.38) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL975684 0.87 SLC29A1 (0.34) SLC29A1MEN1LMNAKMT2AALDH1A1
SCHEMBL25215379 0.84 HTR7 (0.43) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL976008 0.81 HTR7 (0.39) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL23327153 0.80 SLC29A1 (0.33) SLC29A1MEN1LMNAKMT2AALDH1A1
SCHEMBL25249190 0.79 HTR7 (0.45) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL2370354 0.79 SLC29A1 (0.49) SLC29A1MEN1LMNAKMT2AALDH1A1
SCHEMBL25244877 0.78 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL25292470 0.78 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL25293732 0.78 HTR7 (0.46) HTR7HTR1ADRD2HTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289898-B1 Melamine-functional organosilicon compound and making method SHINETSU CHEMICAL CO (JP) 2017-05-03 EP disclosed
US-8263766-B2 Melamine-functional organosilicon compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-09-11 US disclosed
EP-2289898-A1 Melamine-Functional organosilicon compound and making method Shin-Etsu Chemical Co., Ltd. (JP) 2011-03-02 EP disclosed
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD MEN1, MSH6, PRMT6 HTR7 590/4885HTR1A 1403/4885DRD2 1961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.